Clinical study of combination local injection sclerotherapy of bleomycin and OK-432 for intractable lymphatic malformations
Latest Information Update: 14 Oct 2024
At a glance
- Drugs Picibanil (Primary) ; Bleomycin
- Indications Lymphangioma; Lymphatic disorders
- Focus Therapeutic Use
- 14 Oct 2024 New source identified and integrated (Japan Registry of Clinical Trials;jRCTs031180265).
- 04 Aug 2019 Status changed from recruiting to active, no longer recruiting.
- 17 Sep 2016 Status changed from not yet recruiting to recruiting.